Journal of Leukocyte Biology Myeloid cells, immune suppression, tumor immunology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nagase, H.
Right arrow Articles by Hirai, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nagase, H.
Right arrow Articles by Hirai, K.
(Journal of Leukocyte Biology. 2002;71:711-717.)
© 2002 by Society for Leukocyte Biology

Cytokine-mediated regulation of CXCR4 expression in human neutrophils

Hiroyuki Nagase*, Misato Miyamasu{dagger}, Masao Yamaguchi{dagger}, Masako Imanishi{ddagger}, Nelson H. Tsuno§, Kouji Matsushima||, Kazuhiko Yamamoto{dagger}, Yutaka Morita* and Koichi Hirai{ddagger}

Departments of
* Respiratory Medicine,
{dagger} Allergy and Rheumatology,
{ddagger} Bioregulatory Function,
§ Transfusion Medicine, and
|| Molecular Preventive Medicine and CREST, University of Tokyo Graduate School of Medicine, Japan

Correspondence: Koichi Hirai, Department of Bioregulatory Function, University of Tokyo Graduate School of Medicine, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan. E-mail: hiraiko-tky{at}umin.ac.jp


    ABSTRACT
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Several lines of evidence have suggested that a CXC chemokine receptor 4 (CXCR4)/stromal cell-derived factor-1 [SDF-1; CXC chemokine ligand 12 (CXCL12)] pair is involved in baseline trafficking of leukocytes into extravascular tissues and that modulation of surface CXCR4 expression may represent an alternative mechanism for control of cell-specific biological responses to SDF-1/CXCL12. We explored the regulation of CXCR4 expression by cytokines in polymorphonuclear neutrophils (PMNs). No significant surface expression of CXCR4 in freshly isolated PMNs was detected, but expression became apparent gradually during incubation. SDF-1{alpha}/CXCL12 initiated Ca2+ mobilization and migratory responses in 20 h cultured PMNs. The surface CXCR4 expression was suppressed most potently by interferon-{gamma} (IFN-{gamma}). IFN-{alpha}, granulocyte-macrophage colony-stimulating factor (GM-CSF), and G-CSF also inhibited spontaneous CXCR4 expression. Real-time, quantitative PCR experiments revealed that a spontaneous increase and an IFN-{gamma}-mediated decrease in surface CXCR4 paralleled changes in the CXCR4 mRNA level. These results on PMNs support the argument that the SDF-1 (CXCL12)/CXCR4 system is regulated by cell type-specific mechanisms.

Key Words: interferon-{gamma} • granulocyte colony-stimulating factor • granulocyte-macrophage colony-stimulating factor • CXCR1 • CXCR2 • stromal cell-derived factor-1/CXCL12


    INTRODUCTION
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
In recent years, much attention has been focused on the roles of chemokines in various inflammatory settings, because these chemotactic molecules have been implicated in many aspects of leukocyte behavior, including locomotion, adherence, and activation. To date, approximately 40 chemokines have been cloned and are divided into 4 subfamilies based on the 4 conserved, cysteine residues. A CXC chemokine stromal cell-derived factor-1 (SDF-1)/CXC chemokine ligand 12 (CXCL12) was identified originally based on its capacity to promote in vitro growth of lymphocytes of pre-B-cell lineage [1 ] but exerts a broad spectrum of biological effects on various types of leukocytes [2 ]. Local chemokine expression usually occurs in response to proinflammatory stimuli, thus mediating the corresponding leukocyte influx observed during ongoing inflammation of different etiologies. However, in contrast to most other chemokines, SDF-1/CXCL12 is recognized as a "homeostatic" chemokine, being expressed constitutively in almost all tissues with little evidence that it is modulated by inflammatory or immunological stimuli [2 ].

The effects of SDF-1/CXCL12 on target cells are mediated specifically through a G protein-coupled seven-transmembrane receptor, designated CXC chemokine receptor 4 (CXCR4) [3 , 4 ]. CXCR4 mRNA is constitutively expressed in almost all types of leukocytes [2 , 5 ]. Although expression of SDF-1/CXCL12 is hardly regulated by exogenous stimuli, various cytokines have been shown to alter the surface CXCR4 expression level in various leukocytes, indicating that modulation of surface CXCR4 expression may represent an alternative mechanism of control of cell-specific, biological responses to SDF-1/CXCL12. To date, regulation of CXCR4 expression has been studied extensively in lymphocytes [6 7 8 9 ]. In addition, we have shown recently that eosinophil-surface CXCR4 expression is affected strongly by various cytokines [10 ]. Whereas regulation of CXCR4 expression by cytokines has been elucidated gradually, there has been no comprehensive investigation of the regulation of surface CXCR4 expression on polymorphonuclear neutrophils (PMNs). Given the potential importance of alteration of surface CXCR4 expression level in leukocytes, we explored the regulation of PMN CXCR4 expression by cytokines.


    MATERIALS AND METHODS
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Reagents and monoclonal antibodies (mAb)
The reagents used in the experiments were exactly the same as described previously [10 ]. Interferon-{alpha} (IFN-{alpha}), interleukin-10 (IL-10), granulocyte colony-stimulating factor (G-CSF), and IL-8/CXCL8 were purchased from Pepro Tech (London, UK).

Separation and culture of PMNs
Human neutrophils were separated from the blood of normal volunteers by density gradient centrifugation. In brief, buffy coat cells were obtained from venous blood by dextran T500 sedimentation, and eosinophils were eliminated by Percoll (1.088 g/ml; Pharmacia, Uppsala, Sweden) density centrifugation. The buoyant fraction was collected and overlaid on Ficoll-Paque (1.077 g/ml; Pharmacia) to eliminate mononuclear cells. The mean purity of PMNs was 98.4 ± 0.4%, and the viability was consistently >95%.

Neutrophils (0.5–1.0x106) were cultured in RPMI 1640 (Gibco-BRL, Grand Island, NY), supplemented with 10% fetal calf serum (Gibco-BRL) and antibiotics (100 U/ml penicillin and 100 µg/ml streptomycin) at 37°C in 5% CO2 in a total volume of 1 ml in flat-bottom, 48-well culture plates (Costar, Cambridge, MA) for the indicated times.

Flow cytometric analysis of surface CXCR expression on PMNs
Flow cytometric analysis of whole venous blood was performed as described previously [10 ]. In brief, cells were stained with anti-CXCR4-fluorescein isothiocyanate (FITC; 12G5), anti-CXCR2-FITC (48311.211; DAKO, Kyoto, Japan), or anti-CXCR1-FITC (42705.111; DAKO) and anti-CD16-phycoerythrin (PE). Neutrophils were defined on the basis of their specific forward/side-scatter properties, and electronic gates were set on CD16-positive cells to identify PMNs. Mouse immunoglobulin (Ig)G2a-FITC with irrelevant specificity (20102.1) was used as a negative control.

Flow cytometric analysis of isolated PMNs was performed as described previously [11 ]. In brief, cells were preincubated with human IgG (5 mg/ml) followed by incubation with anti-CXCR4 mAb (12G5) or anti-CXCR2 mAb (48311.211). Mouse IgG2a with irrelevant specificity (UPC 10) was used as a negative control. After washing, the cells were stained with FITC-labeled goat F(ab')2 against mouse IgG. Stained PMNs were then analyzed using EPICS XL SYSTEM II (Coulter, Miami, FL). The median values of fluorescence intensity of human PMNs were converted to the numbers of molecules of equivalent soluble fluorochrome (MESF) units as described elsewhere [10 ]. Surface-receptor levels expressed in MESF units were calculated using the following formula: (MESF of PMNs stained by anti-CXCR4 or anti-CXCR2 mAb) - (MESF of PMNs stained by isotype-control mAb).

Apoptosis assay of cultured PMNs
Differential analysis of apoptotic and necrotic cells was performed using a MEBCYTO-Apoptosis Kit (Medical and Biological Lab., Nagoya, Japan), as described previously [10 ]. Apoptotic cells were determined quantitatively by their ability to bind annexin V and exclude propidium iodide (PI). Cells stained with PI were considered to be necrotic cells. In some experiments, PMNs were double-stained with anti-CXCR4 mAb (12G5, 10 µg/ml) followed by a second-step reaction antibody [PE-conjugated goat F(ab')2 against mouse IgG Fc; Beckman Coulter, Tokyo, Japan] and FITC-conjugated annexin V.

Ca2+ mobilization assay of PMNs
Measurement of Ca2+ influx was performed as described previously [10 ]. In brief, purified PMNs (purity: >99%) were resuspended in Hanks’ balanced saline solution with Ca2+ and Mg2+ (Gibco-BRL) and 2% bovine serum albumin at a cell density of 2.0 x 106/ml. Fura-2 AM (Dojindo, Tokyo, Japan) was added at a final concentration of 2 µM. After incubation for 20 min, excess dye was removed by centrifugation, and Ca2+ influx was measured using excitation at 340 and 380 nm on a Hitachi F-2500 fluorescence spectrometer (Hitachi Ltd., Tokyo, Japan). Calibration was performed using 0.1% Triton X for total Ca2+ release and 10 mM ethyleneglycol-bis(ß-aminoethylether)-N,N'-tetraacetic acid to chelate-free Ca2+.

Chemotaxis assay of PMNs
Migration of PMNs was measured using a 6.5 mm diameter, 3 µm pore polycarbonate TranswellTM culture insert (Costar), as described by Bleul et al. [12 ]. In brief, 600 µl aliquots of samples to be tested were transferred to each well of a flat-bottom, 24-well plate, and 5 x 105 purified PMNs in 100 µl RPMI-1640 medium containing 0.25% human serum albumin were introduced into the top chamber. An equal number of purified PMNs were introduced into some lower wells without a top chamber to show the standard count of total cells. After incubation at 37°C, 5% CO2 for 90 min, the cells that had transmigrated into the lower well were suspended vigorously. Approximately 10,000 cells of standard sample were counted, and then other samples containing migrated PMNs were counted for the same duration using flow cytometry. The migration of PMNs was calculated as the percentage of total inoculated cells.

Measurement of cytokine generation by PMNs
Immunoreactive cytokines in the supernatant of cultured PMNs were quantitated using the following enzyme-linked immunosorbent assay (ELISA) kits: IFN-{gamma} (Biosource International, Camarillo, CA), granulocyte-macrophage (GM)-CSF (Genzyme, Minneapolis, MN), and transforming growth factor-ß1 (TGF-ß1; R&D Systems, Minneapolis, MN). Prior to measurement of TGF-ß1, aliquots of supernatant were acidified transiently with HCl for 10 min at room temperature to activate latent TGF-ß1 to its immunoreactive form and then neutralized with NaOH before assay [13 ]. The ELISA methods detected IFN-{gamma}, GM-CSF, and TGF-ß1 concentrations of above 4 pg/ml, 2.8 pg/ml, and 7 pg/ml, respectively.

Analysis of intracellular CXCR4
Mononuclear cells were collected by density gradient centrifugation using Ficoll-Paque (1.077 g/ml). Neutrophils or mononuclear cells were fixed with 4% paraformaldehyde at 4°C for 30 min and resuspended in 0.1% Tween 20 at 4°C for 30 min for permeabilization. After fixation and permeabilization, intracellular CXCR4 was stained and analyzed by flow cytometry as described for surface staining of CXCR4. Lymphocytes were identified on the basis of their forward/side-scatter properties.

Real-time, quantitative polymerase chain reaction (PCR) analysis of CXCR4 mRNA
Total RNA was extracted from PMNs using a QIAGEN RNeasy Mini Kit (Qiagen, Hilden, Germany), and the first-strand cDNA was reverse-transcribed as described previously [14 ]. cDNA was analyzed for human CXCR4 expression by real-time, quantitative PCR using the ABI Prism 7700 Sequence Detection System (PE Applied Biosystems, Foster City, CA). The reaction master mix containing the cDNA sample generated from 10 ng RNA was prepared according to the manufacturer’s protocols to yield final concentrations of 1x Taqman Buffer A, 200 µM dATP, 200 µM dCTP, 200 µM dGTP, 400 µM dUTP, 3.5 mM MgCl2, 1.25 U AmpliTaq Gold DNA polymerase, 200 nM forward and reverse primers, and 100 nM Taqman probe. The CXCR4 gene-specific primers and probe were purchased from PE Applied Biosystems, and their nucleotide sequences were exactly the same as described previously [15 ]. The thermal cycling conditions were as follows: cDNA denaturation, 10 min at 95°C; 48 cycles of denaturation (95°C for 15 s); and annealing/extension (60°C for 1 min). Input cDNA was normalized using a ß-actin primer/probe pair (PE Applied Biosystems) as an internal control gene.

The PCR products of CXCR4 and ß-actin were also analyzed by 2% agarose gel electrophoresis. After ethidium bromide staining, bands were visible only at the expected size for each target mRNA. The standard curve was constructed with serial dilutions of specific PCR products, as described previously [16 ]. In short, CXCR4 or ß-actin PCR products were obtained by amplifying unstimulated PMN cDNA with the same primers and probes as those used for real-time, quantitative PCR. The PCR products were electrophoresed through a 2% agarose gel and visualized with ethidium bromide followed by extraction using QIAEX II (Qiagen), according to the manufacturer’s instructions. The PCR products were quantified spectrophotometrically and stored at -20°C until use. Duplicate standards with copy number controls and no template controls were run in each optical 96-well plate. A negative-control reaction omitting the reverse transcription always showed the lack of a significant amplification signal as a result of contaminating chemokine-receptor DNA.

Statistics
Unless otherwise noted, all data are expressed as the mean ± SE, and differences between values were compared for significance by the paired t-test.


    RESULTS
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Surface expression of CXCR4 in PMNs
In the first series of experiments, surface expression of CXCR4 on whole blood PMNs was analyzed by flow cytometry. Although we detected intense surface expression of CXCR1 and CXCR2 on blood PMNs (Fig. 1A ), we did not find significant surface expression of CXCR4. When PMNs were isolated by gradient centrifugation and likewise, analyzed immediately, we did not detect significant surface CXCR4 expression again (Fig. 1B) . However, when isolated PMNs were cultured for 20 h, considerable amounts of surface CXCR4 protein were observed in these cells. Long-term culture of PMNs results in an increase in apoptotic cells (0.9±0.2%, 1.6±0.1%, and 65.9±1.9% for freshly isolated, 4 h and 20 h cultured PMNs, respectively; n=3). However, surface CXCR4 expression was observed mainly in nonapoptotic PMNs: When 20 h cultured PMNs were double-stained with annexin V and anti-CXCR4 mAb, CXCR4 expression was observed mainly in nonapoptotic, i.e., annexin V-negative, PMNs (Fig. 1C) .



View larger version (47K):
[in this window]
[in a new window]
 
Figure 1. Surface expression of chemokine receptors in PMNs. The shaded area shows the fluorescence of cells stained with isotype-matched mouse IgG2a. (A) Expression of chemokine receptors on PMNs in whole blood. PMNs were identified on the basis of their forward/side-scatter properties, and electronic gates were set on CD16-positive cells to select neutrophils. The fluorescence intensities of gated cells are shown in the right histogram. (B) Surface expression of CXCR2 or CXCR4 in purified PMNs before (0 h) or after incubation for 20 h. (C) Surface expression of CXCR4 in nonapoptotic PMNs. Twenty-hour cultured PMNs were double-stained with anti-CXCR4 mAb or control mouse IgG and FITC-conjugated annexin V (left column). Electronic gates were set on annexin V-negative or -positive cells, and CXCR4 expression was analyzed (right column). All data are representative of three independent experiments, all showing similar results.

 
CXCR4-mediated PMN activation
It has to be mentioned that CXCR4 expressed on PMNs was linked to functional relevance, and the specific ligand SDF-1{alpha}/CXCL12 initiated Ca2+ mobilization and migratory responses in PMNs. Whereas SDF-1{alpha}/CXCL12 was unable to induce an apparent Ca2+ influx in freshly isolated PMNs, it induced strong Ca2+ influx in 20 h cultured PMNs (Fig. 2A ). In addition, freshly isolated PMNs showed only marginal migration toward high concentrations of SDF-1{alpha}/CXCL12, but PMNs cultured for 20 h showed enhanced migratory responses to SDF-1{alpha}/CXCL12 (Fig. 2B) .



View larger version (26K):
[in this window]
[in a new window]
 
Figure 2. Effect of SDF-1{alpha}/CXCL12 on PMNs. (A) Calcium influx induced by IL-8/CXCL8 or SDF-1{alpha}/CXCL12 in purified PMNs just after purification (0 h) or PMNs cultured for 20 h at 37°C. The data shown are representative of two independent analyses from different donors, each showing similar results. The concentration of each chemokine used was 333 ng/ml. (B) Migration of PMNs toward chemokines just after purification (0 h) or after incubation for 20 h at 37°C. The migration-inducing activities of chemokines were indicated as indices calculated using the following formula: (percentage of PMNs migrated toward chemokines)/(percentage of PMNs migrated in medium alone [=Nil]). The percentage of PMNs that migrated in medium alone was 9.25 ± 3.08% (0 h) and 3.63 ± 1.81% (20 h; mean±SE, n=5). The indices are expressed as the mean ± SE (n=5). *, P < 0.05 versus spontaneous migration in medium alone (index=1.0). +, P < 0.05; PMN migration at 0 h versus 24 h.

 
Modulation of surface CXCR4 expression on PMNs by cytokines
Because surface CXCR4 expression by other leukocytes has been shown to be affected strongly by various cytokines [6 7 8 9 10 ], we studied the cytokine-mediated regulation of surface CXCR4 expression in PMNs. As shown in Figure 3 , compared with cells cultured in medium alone, IFN-{gamma} and IFN-{alpha} to a lesser extent suppressed the levels of surface expression of CXCR4. In addition, PMN-directed hemopoietins, i.e., GM-CSF and G-CSF, also down-modulated the expression. Conversely, TGF-ß increased the expression slightly but significantly, whereas none of the other cytokines, including tumor necrosis factor {alpha} (TNF-{alpha}), IL-4, and IL-10, exerted significant effects. Time-kinetic studies demonstrated that spontaneous CXCR4 expression was apparent after 4 h of incubation and increased linearly thereafter up to 20 h (Fig. 4A ). IFN-{gamma} suppressed the expression at all time points with statistical significance. In contrast, surface CXCR2 expression decreased drastically after culturing for 20 h, and IFN-{gamma} exerted no significant effect on CXCR2 expression (Fig. 4A) . Half-maximal inhibition of CXCR4 expression was observed at an IFN-{gamma} concentration of approximately 0.1 ng/ml, a sensitivity compatible with that via interaction with specific IFN-{gamma} receptors (Fig. 4B) .



View larger version (21K):
[in this window]
[in a new window]
 
Figure 3. Effect of cytokines on surface CXCR4 expression in PMNs. PMNs were incubated at 37°C for 20 h, with or without the indicated cytokines, and surface CXCR4 expression was analyzed by flow cytometry. The concentration of each cytokine was 10 ng/ml. The data are expressed as the mean percentage of the calculated value for the MESF units of control cells, which were incubated in medium alone (=Nil). Bars indicate the SE (n=4, except for IFN-{gamma}, IFN-{alpha}, where n=5). *, P < 0.05; **, P < 0.01 versus CXCR4 levels expressed in cells cultured without cytokines (indicated as Nil).

 


View larger version (18K):
[in this window]
[in a new window]
 
Figure 4. Effect of IFN-{gamma} on surface expression of chemokine receptors in PMNs. (A) The time course of surface CXCR4 or CXCR2 expression in purified PMNs. Purified PMNs were cultured with or without 10 ng/ml IFN-{gamma} at 37°C for the indicated times, and their surface CXCR expression was analyzed by flow cytometry. All data are expressed as the mean ± SE (n=3) of the calculated MESF values. *, P < 0.05; **, P < 0.01 versus MESF values of corresponding PMNs cultured without IFN-{gamma}. (B) Dose-dependent effect of IFN-{gamma} on surface CXCR4 expression in PMNs. PMNs were cultured with or without IFN-{gamma} at the indicated concentrations for 20 h at 37°C, and the surface CXCR4 expression was analyzed by flow cytometry. The data are expressed as the percentage of the calculated MESF values of PMNs cultured without IFN-{gamma} (mean±SE, n=4). *, P < 0.05; **, P < 0.01 versus CXCR4 expression in cells cultured without IFN-{gamma}.

 
Although different cytokines, such as IFN-{gamma} and GM-CSF, decreased the surface expression of CXCR4 potently in PMNs, these effects were not mediated by indirect actions resulting from PMN-produced autocrine mechanisms. That is, PMNs cultured with IFN-{gamma} or GM-CSF failed to release GM-CSF or IFN-{gamma} in the supernatant, respectively (n=3; unpublished results). Similarly, significant production of TGF-ß was not detected in PMNs cultured with IFN-{gamma} or GM-CSF.

Mechanisms of CXCR4 expression in PMNs
It has been demonstrated that lymphocytes possess a large cytoplasmic CXCR4 store, which is transported rapidly to the cell surface in response to exogenous stimuli [5 ]. To determine whether similar mechanisms explain spontaneous CXCR4 expression in PMNs, we analyzed intracellular CXCR4 in PMNs and lymphocytes. In contrast to lymphocytes, only marginal levels of intracellular CXCR4 were detected in freshly isolated PMNs (Fig. 5 ). Accordingly, we studied the change in PMN CXCR4 expression at the mRNA level (Fig. 6A and 6B ). Real-time, quantitative PCR experiments showed that the surface CXCR4 expression was regulated at a level of pretranslation: The spontaneous increase in the surface CXCR4 protein was accompanied with increase in the CXCR4 mRNA expression (Fig. 6B) . Conversely, the CXCR4 mRNA expression in IFN-{gamma}-treated PMNs remained low, at levels equivalent to those in freshly isolated PMNs. To elucidate the mechanism of regulation of the CXCR4 mRNA level, we estimated the half-life of CXCR4 mRNA further. It was shown that CXCR4 mRNA has a relatively short half-life of about 2 h in human umbilical vein endothelial cells [17 ] and ~1 h in monocytes [18 ]. In the case of PMNs, we found that the half-life of CXCR4 mRNA was even shorter, and the half-life was shortened further in IFN-{gamma}-treated PMNs: The half-life was 56 min and 42 min (Exp. 1) and 43 min and 31 min (Exp. 2) for untreated and IFN-{gamma}-treated PMNs, respectively (Fig. 7 ). Thus, the reduced levels of CXCR4 mRNA in IFN-{gamma}-treated PMNs were mediated, at least in part by the shortened half-life of CXCR4 mRNA.



View larger version (25K):
[in this window]
[in a new window]
 
Figure 5. CXCR4 staining of PMNs or lymphocytes treated without (upper) or with (lower) fixation procedures. Cell fixation followed by permeabilization was performed as described in Materials and Methods. The shaded area shows the fluorescence of cells stained with isotype-matched mouse IgG2a. The data are representative of three independent experiments, all showing similar results.

 


View larger version (27K):
[in this window]
[in a new window]
 
Figure 6. Quantification of CXCR4 mRNA in PMNs by real-time, quantitative PCR. (A, Upper) Amplification plot of CXCR4 mRNA. cDNA was obtained from purified PMNs (purity>99%) with or without incubation for 4 h in the presence or absence of IFN-{gamma} at 10 ng/ml. {Delta}Rn represents the normalized reporter signal (Rn) minus the baseline signal. (A, Lower) Standard curve-plotting log starting copy number versus threshold cycle (Ct). ({blacklozenge}) Standard samples (Std) plotted in duplicate. The parameter Ct represents the cycle at which the amplification plot passed a fixed threshold. CXCR4 mRNA quantification was linear over a range of 104 copies. The data are representative of three independent experiments, all showing similar results. (B) Relative expression of CXCR4 mRNA. The data are expressed as a ratio: copy number of CXCR4 gene:copy number of ß-actin gene (mean±SE, n=3). **, P < 0.01 between the indicated experimental settings.

 


View larger version (18K):
[in this window]
[in a new window]
 
Figure 7. Effect of IFN-{gamma} on half-life of CXCR4 mRNA in PMNs. PMNs were incubated with 10 µg/ml actinomycin D for the indicated time periods with or without 10 ng/ml IFN-{gamma}. The half-life was 56 min and 42 min (Exp. 1) and 43 min and 31 min (Exp. 2) for untreated and IFN-{gamma}-treated PMNs, respectively. The data are expressed as a ratio: copy number of CXCR4 gene:copy number of ß-actin gene.

 

    DISCUSSION
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
In the present study, we found that resting PMNs, i.e., in whole blood (Fig. 1A) , and freshly isolated PMNs (Fig. 1B) did not express significant levels of surface CXCR4. However, analogous to our previous results for eosinophils [10 ], surface expression of CXCR4 became apparent gradually during incubation. Importantly, PMN CXCR4 expression was coupled to the functional relevance: SDF-1{alpha}/CXCL12 induced an apparent chemotactic response in 20 h cultured cells (Fig. 2B) . So far, studies of the effects of SDF-1/CXCL12 on PMNs have yielded conflicting results. Although some groups observed chemotaxis or Ca2+ influx upon stimulation with SDF-1/CXCL12 [4 , 19 ], another group was unable to induce significant chemotaxis [12 ]. The latter group used simple, one-step Ficoll-Hypaque centrifugation [12 , 20 ], whereas the former groups used more complicated and time-consuming methods using glass-bead treatment [4 , 21 ] or analyzed PMNs isolated from the leukocytes in transfusion blood [19 , 22 ]. Our present results strongly suggest that the conflicting observations concerning the expression and function of PMN CXCR4 may be explained as consequences of different separation conditions, such as the length of isolation procedures.

In contrast to IL-8/CXCL8, which is up-regulated transcriptionally by inflammatory and immunological stimuli (reviewed in ref. [23 ]), SDF-1/CXCL12 is expressed ubiquitously in almost all tissues, with little evidence of modulation of expression by exogenous stimulation [2 ]. These facts indicate that SDF-1/CXCL12 plays a role in baseline trafficking of PMNs into extravascular tissues rather than in recruiting PMNs to inflammatory sites. Although expression of SDF-1/CXCL12 was hardly modulated by exogenous stimuli, various cytokines were able to modulate surface CXCR4 expression in leukocytes, indicating that the biological action is probably regulated at the level of CXCR4 receptor expression. Of particular importance is that surface CXCR4 expression is regulated in a stimulus- and cell-specific way. For example, IL-4 up-regulates [6 7 8 ], and IFN-{gamma} down-regulates [9 ] CXCR4 expression in T cells, and both cytokines exerted exactly the opposite effects on eosinophil CXCR4 expression [10 ]. In the present study, we investigated the effects of cytokines on CXCR4 expression in PMNs and found that the profile for cytokine-mediated regulation of PMN CXCR4, such as the effect of IFN-{gamma}, is different from the profiles in other types of leukocytes such as eosinophils [10 ]. These findings extend our previous knowledge that the SDF-1 (CXCL12)/CXCR4 system is regulated by cell-type-specific mechanisms, which may be important in predicting the fate of each cell type during inflammatory processes of different etiology.

PMN CXCR4 expression was down-regulated by G-CSF and GM-CSF. In vitro studies have demonstrated that G-CSF (reviewed in ref. [24 ]) and GM-CSF (reviewed in ref. [25 ]) stimulate mature PMN functions, including degranulation, phagocytosis, adhesion, and chemokinesis. Furthermore, G-CSF may modulate PMN function in vivo, because G-CSF levels are often elevated in the serum or inflammatory sites in septic patients [26 ]. It is interesting that G-CSF was shown to up-regulate the expression of CXCR1/CXCR2 and intensify the chemotaxis of PMNs toward IL-8/CXCL8 [27 ]. Thus, under G-CSF-rich conditions, such as septic states, G-CSF may render circulating PMNs more sensitive to IL-8/CXCL8, thereby facilitating PMN migration from the circulation into affected tissues. Our present results that G-CSF and GM-CSF down-regulated surface CXCR4 expression in PMNs are also in line with this assumption. The decrease in CXCR4 expression caused by G-CSF and GM-CSF may decelerate the movement of PMNs from the circulation to noninflamed tissues expressing SDF-1/CXCL12, which in turn shifts the distribution of PMNs in favor of inflamed tissues.

Surface expression of CXCR4 on PMNs was most potently suppressed by IFN-{gamma}. Bonecchi et al. [28 ] demonstrated that IFN-{gamma} induces the expression of CC chemokine receptor 1 (CCR1) and CCR3 in PMNs. They also described that IFN-{gamma} inhibited CXCR4 mRNA accumulation in some donors, albeit they have not studied the change in surface expression [28 ]. Although it has been well-documented that IFN-{gamma} can activate multiple PMN functions (reviewed in ref. [29 ]), a role for IFN-{gamma} in PMN distribution is totally speculative. The fact that PMNs are a cellular source of IL-12 [30 ] may indicate a possible role of PMNs under T-helper cell type 1 (Th1)-dominant conditions, and a Th1-dominant situation may lead to an increase in the PMN influx to inflammatory sites via down-regulation of CXCR4 by IFN-{gamma}. The present data showing down-regulation of CXCR4 in PMNs may suggest an additional aspect of Th1 response induced by IFN-{gamma}.

In summary, we have demonstrated that functional expression of CXCR4 is inducible in PMNs and that SDF-1{alpha}/CXCL12 elicits apparent migration in CXCR4-expressed PMNs. IFN-{gamma}, G-CSF, and GM-CSF inhibited CXCR4 expression. Because alteration of surface CXCR4 expression may be implicated in the in vivo distribution of leukocytes, a more comprehensive understanding of the role of CXCR4/SDF-1 (CXCL12) in normal and disordered conditions should be pursued.


    ACKNOWLEDGEMENTS
 
This work was supported by a grant from the Manabe Medical Foundation and by grants-in-aid from the Ministry of Health, Welfare and Labor of Japan and the Ministry of Education, Science, Sports and Culture of Japan (to K. H.). H. N. is a Research Fellow of the Japan Society for the Promotion of Science. We thank Ms. Chise Tamura and Ms. Sachiko Takeyama for their excellent technical assistance and secretarial help, respectively.

Received September 26, 2000; revised November 29, 2001; accepted December 19, 2001.


    REFERENCES
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 

  1. Nagasawa, T., Kikutani, H., Kishimoto, T. (1994) Molecular cloning and structure of a pre-B-cell growth-stimulating factor Proc. Natl. Acad. Sci. USA 91,2305-2309[Abstract/Free Full Text]
  2. Nagasawa, T., Tachibana, K., Kawabata, K. (1999) A CXC chemokine SDF-1/PBSF: a ligand for a HIV coreceptor, CXCR4 Adv. Immunol. 71,211-228[Medline]
  3. Bleul, C. C., Farzan, M., Choe, H., Parolin, C., Clark-Lewis, I., Sodroski, J., Springer, T. A. (1996) The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry Nature 382,829-833[Medline]
  4. Oberlin, E., Amara, A., Bachelerie, F., Bessia, C., Virelizier, J. L., Arenzana-Seisdedos, F., Schwartz, O., Heard, J. M., Clark-Lewis, I., Legler, D. F., Loetscher, M., Baggiolini, M., Moser, B. (1996) The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1 Nature 382,833-835[Medline]
  5. Forster, R., Kremmer, E., Schubel, A., Breitfeld, D., Kleinschmidt, A., Nerl, C., Bernhardt, G., Lipp, M. (1998) Intracellular and surface expression of the HIV-1 coreceptor CXCR4/fusin on various leukocyte subsets: rapid internalization and recycling upon activation J. Immunol. 160,1522-1531[Abstract/Free Full Text]
  6. Wang, J., Harada, A., Matsushita, S., Matsumi, S., Zhang, Y., Shioda, T., Nagai, Y., Matsushima, K. (1998) IL-4 and a glucocorticoid up-regulate CXCR4 expression on human CD4+ T lymphocytes and enhance HIV-1 replication J. Leukoc. Biol. 64,642-649[Abstract]
  7. Jourdan, P., Abbal, C., Nora, N., Hori, T., Uchiyama, T., Vendrell, J. P., Bousquet, J., Taylor, N., Pene, J., Yssel, H. (1998) IL-4 induces functional cell-surface expression of CXCR4 on human T cells J. Immunol. 160,4153-4157[Abstract/Free Full Text]
  8. Valentin, A., Lu, W., Rosati, M., Schneider, R., Albert, J., Karlsson, A., Pavlakis, G. N. (1998) Dual effect of interleukin 4 on HIV-1 expression: implications for viral phenotypic switch and disease progression Proc. Natl. Acad. Sci. USA 95,8886-8891[Abstract/Free Full Text]
  9. Annunziato, F., Cosmi, L., Galli, G., Beltrame, C., Romagnani, P., Manetti, R., Romagnani, S., Maggi, E. (1999) Assessment of chemokine receptor expression by human Th1 and Th2 cells in vitro and in vivo J. Leukoc. Biol. 65,691-699[Abstract]
  10. Nagase, H., Miyamasu, M., Yamaguchi, M., Fujisawa, T., Ohta, K., Yamamoto, K., Morita, Y., Hirai, K. (2000) Expression of CXCR4 in eosinophils: functional analyses and cytokine-mediated regulation J. Immunol. 164,5935-5943[Abstract/Free Full Text]
  11. Nagase, H., Miyamasu, M., Yamaguchi, M., Kawasaki, H., Ohta, K., Yamamoto, K., Morita, Y., Hirai, K. (2000) Glucocorticoids preferentially up-regulate functional CXCR4 expression in eosinophils J. Allergy Clin. Immunol. 106,1132-1139[Medline]
  12. Bleul, C. C., Fuhlbrigge, R. C., Casasnovas, J. M., Aiuti, A., Springer, T. A. (1996) A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1) J. Exp. Med. 184,1101-1109[Abstract/Free Full Text]
  13. Fava, R. A., Olsen, N. J., Postlethwaite, A. E., Broadley, K. N., Davidson, J. M., Nanney, L. B., Lucas, C., Townes, A. S. (1991) Transforming growth factor beta 1 (TGF-beta 1) induced neutrophil recruitment to synovial tissues: implications for TGF-beta-driven synovial inflammation and hyperplasia J. Exp. Med. 173,1121-1132[Abstract/Free Full Text]
  14. Miyamasu, M., Nakajima, T., Misaki, Y., Izumi, S., Tsuno, N., Kasahara, T., Yamamoto, K., Morita, Y., Hirai, K. (1999) Dermal fibroblasts represent a potent major source of human eotaxin: in vitro production and cytokine-mediated regulation Cytokine 11,751-758[Medline]
  15. Patterson, B. K., Landay, A., Andersson, J., Brown, C., Behbahani, H., Jiyamapa, D., Burki, Z., Stanislawski, D., Czerniewski, M. A., Garcia, P. (1998) Repertoire of chemokine receptor expression in the female genital tract: implications for human immunodeficiency virus transmission Am. J. Pathol. 153,481-490[Abstract/Free Full Text]
  16. Bieche, I., Olivi, M., Champeme, M. H., Vidaud, D., Lidereau, R., Vidaud, M. (1998) Novel approach to quantitative polymerase chain reaction using real-time detection: application to the detection of gene amplification in breast cancer Int. J. Cancer 78,661-666[Medline]
  17. Gupta, S. K., Lysko, P. G., Pillarisetti, K., Ohlstein, E., Stadel, J. M. (1998) Chemokine receptors in human endothelial cells. Functional expression of CXCR4 and its transcriptional regulation by inflammatory cytokines J. Biol. Chem. 273,4282-4287[Abstract/Free Full Text]
  18. Saccani, A., Saccani, S., Orlando, S., Sironi, M., Bernasconi, S., Ghezzi, P., Mantovani, A., Sica, A. (2000) Redox regulation of chemokine receptor expression Proc. Natl. Acad. Sci. USA 97,2761-2766[Abstract/Free Full Text]
  19. Ueda, H., Siani, M. A., Gong, W., Thompson, D. A., Brown, G. G., Wang, J. M. (1997) Chemically synthesized SDF-1alpha analogue, N33A, is a potent chemotactic agent for CXCR4/Fusin/LESTR-expressing human leukocytes J. Biol. Chem. 272,24966-24970[Abstract/Free Full Text]
  20. Roth, S. J., Carr, M. W., Springer, T. A. (1995) C-C chemokines, but not the C-X-C chemokines interleukin-8 and interferon-gamma inducible protein-10, stimulate transendothelial chemotaxis of T lymphocytes Eur. J. Immunol. 25,3482-3488[Medline]
  21. Weening, R. S., Roos, D., Loos, J. A. (1974) Oxygen consumption of phagocytizing cells in human leukocyte and granulocyte preparations: a comparative study J. Lab. Clin. Med. 83,570-577[Medline]
  22. Xu, L. L., McVicar, D. W., Ben-Baruch, A., Kuhns, D. B., Johnston, J., Oppenheim, J. J., Wang, J. M. (1995) Monocyte chemotactic protein-3 (MCP3) interacts with multiple leukocyte receptors: binding and signaling of MCP3 through shared as well as unique receptors on monocytes and neutrophils Eur. J. Immunol. 25,2612-2617[Medline]
  23. Roebuck, K. A. (1999) Regulation of interleukin-8 gene expression J. Interferon Cytokine Res. 19,429-438[Medline]
  24. Betsuyaku, T., Liu, F., Senior, R. M., Haug, J. S., Brown, E. J., Jones, S. L., Matsushima, K., Link, D. C. (1999) A functional granulocyte colony-stimulating factor receptor is required for normal chemoattractant-induced neutrophil activation J. Clin. Investig. 103,825-832[Medline]
  25. Brizzi, M. F., Aronica, M. G., Rosso, A., Bagnara, G. P., Yarden, Y., Pegoraro, L. (1996) Granulocyte-macrophage colony-stimulating factor stimulates JAK2 signaling pathway and rapidly activates p93fes, STAT1 p91, and STAT3 p92 in polymorphonuclear leukocytes J. Biol. Chem. 271,3562-3567[Abstract/Free Full Text]
  26. Cebon, J., Layton, J. E., Maher, D., Morstyn, G. (1994) Endogenous haemopoietic growth factors in neutropenia and infection Br. J. Haematol. 86,265-274[Medline]
  27. Lloyd, A. R., Biragyn, A., Johnston, J. A., Taub, D. D., Xu, L., Michiel, D., Sprenger, H., Oppenheim, J. J., Kelvin, D. J. (1995) Granulocyte-colony stimulating factor and lipopolysaccharide regulate the expression of interleukin 8 receptors on polymorphonuclear leukocytes J. Biol. Chem. 270,28188-28192[Abstract/Free Full Text]
  28. Bonecchi, R., Polentarutti, N., Luini, W., Borsatti, A., Bernasconi, S., Locati, M., Power, C., Proudfoot, A., Wells, T. N., Mackay, C., Mantovani, A., Sozzani, S. (1999) Up-regulation of CCR1 and CCR3 and induction of chemotaxis to CC chemokines by IFN-gamma in human neutrophils J. Immunol. 162,474-479[Abstract/Free Full Text]
  29. Cassatella, M. A. (1999) Neutrophil-derived proteins: selling cytokines by the pound Adv. Immunol. 73,369-509[Medline]
  30. Cassatella, M. A., Meda, L., Gasperini, S., D’Andrea, A., Ma, X., Trinchieri, G. (1995) Interleukin-12 production by human polymorphonuclear leukocytes Eur. J. Immunol. 25,1-5[Medline]



This article has been cited by other articles:


Home page
FASEB J.Home page
R. C. Furze and S. M. Rankin
The role of the bone marrow in neutrophil clearance under homeostatic conditions in the mouse
FASEB J, September 1, 2008; 22(9): 3111 - 3119.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
C. Bogani, V. Ponziani, P. Guglielmelli, C. Desterke, V. Rosti, A. Bosi, M.-C. Le Bousse-Kerdiles, G. Barosi, A. M. Vannucchi, and for the Myeloproliferative Disorders Research Cons
Hypermethylation of CXCR4 Promoter in CD34+ Cells from Patients with Primary Myelofibrosis
Stem Cells, August 1, 2008; 26(8): 1920 - 1930.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. M. Kerfoot, G. Andonegui, C. S. Bonder, and L. Liu
Exogenous stromal cell-derived factor-1 induces modest leukocyte recruitment in vivo
Am J Physiol Heart Circ Physiol, June 1, 2008; 294(6): H2524 - H2534.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Ophthalmol.Home page
I A Bhutto, D S McLeod, C Merges, T Hasegawa, and G A Lutty
Localisation of SDF-1 and its receptor CXCR4 in retina and choroid of aged human eyes and in eyes with age related macular degeneration
Br. J. Ophthalmol., July 1, 2006; 90(7): 906 - 910.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. J. Lum, G. Bren, R. McClure, and A. D. Badley
Elimination of Senescent Neutrophils by TNF-Related Apotosis-Inducing Ligand
J. Immunol., July 15, 2005; 175(2): 1232 - 1238.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
A. Katayama, T. Ogino, N. Bandoh, S. Nonaka, and Y. Harabuchi
Expression of CXCR4 and Its Down-Regulation by IFN-{gamma} in Head and Neck Squamous Cell Carcinoma
Clin. Cancer Res., April 15, 2005; 11(8): 2937 - 2946.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
R. M. Rao, T. V. Betz, D. J. Lamont, M. B. Kim, S. K. Shaw, R. M. Froio, F. Baleux, F. Arenzana-Seisdedos, R. Alon, and F. W. Luscinskas
Elastase Release by Transmigrating Neutrophils Deactivates Endothelial-bound SDF-1{alpha} and Attenuates Subsequent T Lymphocyte Transendothelial Migration
J. Exp. Med., September 20, 2004; 200(6): 713 - 724.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. Schaerli, M. Britschgi, M. Keller, U. C. Steiner, L. S. Steinmann, B. Moser, and W. J. Pichler
Characterization of Human T Cells That Regulate Neutrophilic Skin Inflammation
J. Immunol., August 1, 2004; 173(3): 2151 - 2158.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
B. T. Suratt, J. M. Petty, S. K. Young, K. C. Malcolm, J. G. Lieber, J. A. Nick, J.-A. Gonzalo, P. M. Henson, and G. S. Worthen
Role of the CXCR4/SDF-1 chemokine axis in circulating neutrophil homeostasis
Blood, July 15, 2004; 104(2): 565 - 571.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J.-P. Levesque, F. Liu, P. J. Simmons, T. Betsuyaku, R. M. Senior, C. Pham, and D. C. Link
Characterization of hematopoietic progenitor mobilization in protease-deficient mice
Blood, July 1, 2004; 104(1): 65 - 72.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Lenoir, B. Djerdjouri, and A. Perianin
Stroma Cell-Derived Factor 1{alpha} Mediates Desensitization of Human Neutrophil Respiratory Burst in Synovial Fluid from Rheumatoid Arthritic Patients
J. Immunol., June 1, 2004; 172(11): 7136 - 7143.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. Nagase, S. Okugawa, Y. Ota, M. Yamaguchi, H. Tomizawa, K. Matsushima, K. Ohta, K. Yamamoto, and K. Hirai
Expression and Function of Toll-Like Receptors in Eosinophils: Activation by Toll-Like Receptor 7 Ligand
J. Immunol., October 15, 2003; 171(8): 3977 - 3982.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nagase, H.
Right arrow Articles by Hirai, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nagase, H.
Right arrow Articles by Hirai, K.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS